BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Total debt minus cash and cash equivalents
3Y CAGR
-3.9%/yr
vs +87.8%/yr prior
5Y CAGR
+120.9%/yr
Recent deceleration
Acceleration
-91.7pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
52.6x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $387.59M | -47.4% |
| 2024 | $736.50M | +3.1% |
| 2023 | $714.50M | +63.6% |
| 2022 | $436.69M | +391.5% |
| 2021 | $88.85M | +1104.7% |
| 2020 | $7.38M | +125.0% |
| 2019 | $-29.52M | -184.1% |
| 2018 | $35.09M | +690.4% |
| 2017 | $4.44M | -86.0% |
| 2016 | $31.62M | - |